THURSDAY, MAY 25, 2017

Infant development appears normal after antimalarial treatment for pregnant women

Research from the University of Barcelona shows that antimalarial mefloquine (MQ) treatments administered during pregnancy did not seem to affect the early development of infants involved in the research. Read More »

Experimental Ebola drug ZMapp requires further research

ZMapp, an experimental treatment for the Ebola virus, may be beneficial to Ebola patients but there is still a lack of data from its developer, Mapp Biopharmaceutical Inc., to determine whether it can be used to treat humans. Read More »

Recombinase approach for HIV therapy could set new development trend

Medical faculty of the Dresden Technical University (TUD) and the Heinrich Pette Institute's (HPI) Leibniz Institute for Experimental Virology have developed a new recombinase, Brec1, to make a therapy for HIV infections. Read More »

African health officials poised to vaccinate every child

Health officials are prepared to provide every child in Africa with life-saving vaccines, as the continent is in a prime position to fulfill the opportunities and potential that it has to give a better quality of life to its future generations. Read More »

Majority of 82 Ebola survivors involved in study report continuing brain symptoms

A recent study of the world’s biggest Ebola outbreak shows the majority of the 82 survivors have experienced brain symptoms over six months after they contracted their Ebola infections. Read More »

CDC ranks flu vaccine as 60 percent effective

Officials from the Centers for Disease Control and Prevention (CDC) recently stated that preliminary overall influenza vaccine effectiveness amounts to 59 percent for this influenza season. Read More »

Colorado State researchers find new dengue fever diagnosis method

Researchers from Colorado State University may have found a way to use small molecules to diagnose dengue fever, possibly also determining the progression of the illness. Read More »

Study shows antidepressant may relieve cognitive symptoms in HIV patients

The antidepressant Paroxetine has been shown to modestly relief cognitive symptoms in patients who have HIV, including reaction time, decision-making and inflammation. Read More »